BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16908804)

  • 1. N-acetylcysteine for contrast nephropathy: more clinical science is required.
    Eddleston M; Goddard J; Bateman N
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetylcysteine to prevent contrast nephropathy.
    Meine TJ; Washam JB
    Am Heart J; 2004 Mar; 147(3):440-1. PubMed ID: 14999191
    [No Abstract]   [Full Text] [Related]  

  • 3. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From chaotic to coordinated clinical research: the case of acetylcysteine.
    Biondi-Zoccai GG; Abbate A; Valgimigli M; Testa L; Agostoni P
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668; author reply 1669. PubMed ID: 16908805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
    Rizzato G
    Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephropathy caused by radiocontrast media].
    Kolarz M; Sułowicz W
    Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-induced nephropathy: a review.
    Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
    Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization.
    Nunag M; Brogan M; Garrick R
    Cardiol Rev; 2009; 17(6):263-9. PubMed ID: 19829174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
    Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
    J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
    Bagshaw SM; McAlister FA; Manns BJ; Ghali WA
    Arch Intern Med; 2006 Jan; 166(2):161-6. PubMed ID: 16432083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of contrast nephropathy: myth or reality?].
    Ponte B; Saudan P
    Rev Med Suisse; 2005 Feb; 1(8):563-7. PubMed ID: 15794306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 14. Can we prevent acute kidney injury?
    Venkataraman R
    Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine and contrast-induced nephropathy.
    Balderramo DC
    N Engl J Med; 2006 Oct; 355(14):1498-9; author reply 1499-500. PubMed ID: 17024740
    [No Abstract]   [Full Text] [Related]  

  • 16. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?
    Mehran R; Brar S; Dangas G
    J Am Coll Cardiol; 2010 May; 55(20):2210-1. PubMed ID: 20466201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to prevent contrast nephropathy.
    Oudemans-van Straaten HM
    Minerva Cardioangiol; 2005 Oct; 53(5):445-63. PubMed ID: 16179886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.